Ocular complications with high-dose interferon alpha in chronic active hepatitis
- 1 March 1999
- journal article
- clinical trial
- Published by Springer Nature in Eye
- Vol. 13 (2) , 241-246
Abstract
Purpose Interferon alpha, which is used to treat various systemic disorders, has many reversible side-effects involving various organ systems. In this study, chronic active hepatitis patients undergoing interferon alpha therapy were followed with regard to the ocular side-effects. Methods Thirty-six patients with chronic active hepatitis undergoing subcutaneous interferon alpha therapy for 1 year were enrolled. Complete ocular examination and photographic documentation were performed at baseline of the therapy and monthly thereafter. Fisher's exact chi-squared test and Mann-Whitney U-test were employed in the statistical evaluation of the results. Results Trichomegaly was noted in 2 (6%) patients. Fifteen patients (42%) were found to have retinopathy with cotton wool spot formation and splinter haemorrhages. Conclusions These findings emphasise the need to monitor these retinal complications, which may result in loss of vision in patients receiving interferon alpha therapy.Keywords
This publication has 12 references indexed in Scilit:
- Interferon Alfa Induces Leukocyte Capillary Trapping in Rat Retinal MicrocirculationArchives of Ophthalmology (1950), 1996
- Interferone-assoziierte RetinopathieKlinische Monatsblätter für Augenheilkunde, 1995
- Interferon alfa-2a modifies the course of subfoveal and juxtafoveal choroidal neovascularisation.British Journal of Ophthalmology, 1994
- The Treatment of Choroidal Neovascular Membranes by Alpha InterferonOphthalmology, 1994
- Interferon-Associated RetinopathyArchives of Ophthalmology (1950), 1993
- The InterferonsJAMA, 1991
- The interferons. Mechanisms of action and clinical applicationsJAMA, 1991
- Treatment of Chronic Hepatitis B with Interferon: Experience in Western CountriesSeminars in Liver Disease, 1989
- Induction of acute corneal allograft rejection by alpha-2 interferonThe American Journal of Medicine, 1987
- Treatment of Advanced Non-Hodgkin's Lymphoma with Recombinant Leukocyte a InterferonNew England Journal of Medicine, 1984